ResMed Inc. (NYSE:RMD – Get Rating) – Equities research analysts at KeyCorp raised their FY2023 earnings estimates for shares of ResMed in a note issued to investors on Thursday, April 27th. KeyCorp analyst M. Mishan now expects that the medical equipment provider will post earnings of $6.53 per share for the year, up from their […]
ResMed (NYSE:RMD – Get Rating) announced its quarterly earnings results on Thursday. The medical equipment provider reported $1.68 EPS for the quarter, beating analysts’ consensus estimates of $1.58 by $0.10, Briefing.com reports. ResMed had a net margin of 21.51% and a return on equity of 25.46%. The business had revenue of $1.12 billion for the […]